SCHEMBL3466770

SCHEMBL3466770

CC(C)(C)OC(=O)N(c1ccccc1)S(=O)(=O)c1ccc(CCCC(CCc2ccc(-c3cccc(C#N)c3)cc2)C(=O)O)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 2/20 0.45
MMP12 P39900 1/20 0.45
ADAMTS4 O75173 2/20 0.41
PTPN2 P17706 1/20 0.40
PTPN1 P18031 1/20 0.40
STAT3 P40763 1/20 0.40
PTPRS Q13332 1/20 0.40
MMP3 P08254 6/20 0.38
MMP2 P08253 5/20 0.38
FOLH1 Q04609 1/20 0.36
CTSS P25774 2/20 0.36
CTSK P43235 2/20 0.36
CTSB P07858 1/20 0.36
MCHR1 Q99705 1/20 0.35
CNR1 P21554 1/20 0.35
CNR2 P34972 1/20 0.35
MME P08473 1/20 0.35
PTGER2 P43116 1/20 0.34
GPR88 Q9GZN0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467062 0.93 MMP13 (0.43) MMP13MMP12ADAMTS4PTPN2PTPN1
SCHEMBL3465873 0.90 MMP13 (0.42) MMP13MMP12ADAMTS4PTPN2PTPN1
SCHEMBL3469957 0.83 PTPN2 (0.40) MMP13MMP12ADAMTS4PTPN2PTPN1
SCHEMBL7928277 0.82 MMP12 (0.64) MMP13MMP12ADAMTS4MMP3MMP2
SCHEMBL7932591 0.81 MMP12 (0.63) MMP13MMP12ADAMTS4MMP3MMP2
SCHEMBL3467248 0.78 MMP13 (0.51) MMP13MMP12ADAMTS4MMP3MMP2
SCHEMBL3469959 0.78 STAT3 (0.42) MMP13MMP12ADAMTS4PTPN2PTPN1
SCHEMBL1855701 0.78 MMP2 (0.41) MMP3MMP2MCHR1
SCHEMBL3467263 0.77 PTPN2 (0.39) MMP13MMP12ADAMTS4PTPN2PTPN1
SCHEMBL7928937 0.76 MMP12 (0.54) MMP13MMP12MMP3MMP2FOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO claimed
WO-2010070076-A1 ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2010-06-24 WO disclosed